InsidersTradesSigma
Explore the complete record of transactions filed by Roemer Alan S., Director. Director active across 1 companies, notably NexImmune, Inc.. Aggregated, 2 reports have been recorded. The latest transaction was disclosed on 21 December 2021 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Alan S. Roemer is a Director at NexImmune, Inc. He participates in the governance of the company and in defining its strategy to promote innovation in the biotechnology sector.